GAO says the US FDA unable to regulate off-label promotion
This article was originally published in Scrip
Executive Summary
A report from the US Government Accountability Office(GAO) says that the US FDAis hampered in its ability to properly oversee off-label promotion because it does not have staff specifically assigned to catch companies in off-label promotion.